ArticleEndocrine2025

Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database.

Jianxing Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.